InsidersTradesSigma
Follow the 蓝帆医疗 share price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 蓝帆医疗 has recorded 5 insider filings. Market capitalisation: €5.9bn. The latest transaction was reported on 20 March 2026 (Purchase). Among the most active insiders: 于苏华. All data is free.
5
Insider Decl.
n/a
Thresholds
€681,912
3 ops.
Buy Volume
€1,929
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,710 of 29,063 companies
19.8
score / 100
Value23
Quality16
FCF yld-1.6%
Earn yld-13%
EV/EBITDA·
ROE-8.8%
Gross mgn16%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 March 2026
Declarations5 total
5 of 5 declarations
Acerca de 蓝帆医疗
蓝帆医疗 es una empresa centrada en el sector de la salud y farmacéutico, que ofrece productos médicos y soluciones sanitarias. Cotiza en el mercado XSHE.